Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IndividualfiledCriticalIndividual
Publication of ES406450A1publicationCriticalpatent/ES406450A1/en
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Procedure for the preparation of arginine malate, according to a compound corresponding to the formula ** (see formula) ** Which is characterized by the addition, by stirring, to an equivalent amount of arginine, an equivalent of malic acid, dissolved in water or in primary aliphatic alcohol of 1-3 carbon atoms; by concentrating the resulting solution to dryness; by taking the residue again with little alcohol; and by filtering and drying, obtaining, with 95% yield, a solid, crystalline, white product, at p.f. 222-225º with dec. (Machine-translation by Google Translate, not legally binding)
ES406450A1971-09-131972-09-07Procedure for the preparation of arginine malate. (Machine-translation by Google Translate, not legally binding)
ExpiredES406450A1
(en)
Procedure for the preparation of N- (r-tetrahydrofurfuril) -noroximorphone and N- (s-tetrahydrofurfuril) -noroximorphone new. (Machine-translation by Google Translate, not legally binding)
A process for preparing new esters of n, n'-di- (bethydroxyethyl) -piperazine of alpha-substitute 1-nafthyl acetyces. (Machine-translation by Google Translate, not legally binding)
Procedure for the preparation of effective compounds in the treatment of bronchospastic conditions. (Machine-translation by Google Translate, not legally binding)